Market Tracker

08/26 5:16pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

402.97
Delayed Data
As of Aug 26
 +2.72 / +0.68%
Today’s Change
329.09
Today|||52-Week Range
592.59
-25.77%
Year-to-Date

Today’s Trading

Previous close400.25
Today’s open400.00
Day’s range396.21 - 407.04
Volume664,326
Average volume (3 months)861,448
Market cap$42.4B
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-9.33%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+45.55%
P/E ratio62.9
Price/Sales15.24
Price/Book11.54

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+0.46+0.36%
SHPGShire-0.99-0.52%
ZTSZoetis Inc+0.29+0.57%
VRTXVertex Pharmaceutica...+0.71+0.74%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$2.76
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts